Online Education | Women's Health Drug Therapy 2013 - Osteoporosis Update 2013
This online module discusses recently updated guidelines for calcium and vitamin D supplementation, discusses the controversies surrounding bisphosphonate therapy and describes two newer treatment options for osteoporosis: denosumab and teriparatide.
This course was recorded in May 2013 at a conference provided by Continuing Nursing Education at the University of Washington School of Nursing. Teaching methods include video, audio and handouts.
Publish Date: January 16, 2014. This course will be available for three years from this date.
To register, click the Register button. If already registered, click the Continue button to go to your course.
This online course is designed as a pharmacology update for nurse practitioners, clinical nurse specialists, nurses and healthcare professionals in all settings. Each module focuses on current recommendations and pharmacotherapeutic principles for women's health problems commonly seen in primary care.
Objectives for Learning Outcomes
- Discuss recently updated guidelines for calcium and vitamin D supplementation.
- Discuss the controversies surrounding bisphosphonate therapy.
- Describe two newer treatment options for osteoporosis: denosumab and teriparatide.
Heather Kramm, MD
Rheumatologist, The Seattle Arthritis Clinic, Seattle
- 1.20 Contact hours
- 1.20 Pharmacology hours at the advanced practice level